Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of congestive heart failure ("CHF") and related conditions. CHF is a life-threatening condition afflicting nearly 5 million Americans and responsible for 2.5 million hospital admissions each year. Given their poor state of health, CHF patients are rarely candidates for conventional surgical procedures that could extend and improve their lives. Cardiac Dimensions is developing minimally invasive therapies as an alternative to surgery, thus significantly expanding the pool of CHF patients that can be helped. Cardiac Dimensions, based in Seattle, Washington was founded in 2001 by Scout Medical Technologies, and is funded by leading venture capital firms MPM Capital, Polaris Venture Partners and InterWest Partners.
Cardiac Dimensions Address
5540 Lake Washington Blvd. NE Kirkland, WA United States